Fluzone (influenza vaccine) is safe to receive while pregnant or breastfeeding. Certain factors, including the risks of not receiving the vaccine during pregnancy, may determine whether you should ...

Fluzone High-Dose was 24.2% more effective in preventing influenza in adults aged 65 years or older than regular Fluzone in a large-scale clinical trial, vaccine maker Sanofi Pasteur told the Advisory ...

The US Food and Drug Administration (FDA) has approved Fluzone (Sanofi) high-dose quadrivalent influenza vaccine for adults aged 65 years and older. This approval is the final step toward the ...

FDA approves Fluzone ® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older *Will be available in fall 2020, in time for the 2020-2021 flu season PARIS - November 4, 2019 – ...

Fluzone is a brand-name vaccine used to help prevent certain types of flu. Fluzone comes in two forms: Fluzone Quadrivalent and Fluzone High-Dose Quadrivalent. Fluzone’s cost with and without ...

The approval was based on findings from a Phase 4 safety and immunogenicity study that included ~2000 children. The Food and Drug Administration (FDA) has approved the expanded use of Fluzone ...

Last year, Sanofi's ($SNY) fourth-quarter flu vaccine sales soared on the introduction of a quadrivalent contender, surging more than 94%. Now, looking to keep that ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a supplemental Biologic License Application for the Fluzone High-Dose Quadrivalent vaccine for ...

Quadrivalent inactivated "split virus" influenza vaccine (Types A and B); 0.25mL dose contains a total of 30mcg of influenza virus hemmagglutinin; 0.5mL dose contains a total of 60mcg of influenza ...

Fluzone (influenza vaccine) is a brand-name vaccine that’s prescribed to help prevent influenza (the flu). Fluzone isn’t known to interact with other drugs. An interaction occurs when one substance ...

PARIS - November 4, 2019 – The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for use in ...

PARIS, Nov. 4, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for ...